Cargando…
Differentiation Syndrome in Promyelocytic Leukemia: Clinical Presentation, Pathogenesis and Treatment
Differentiation syndrome (DS) represents a life-threatening complication in patients with acute promyelocytic leukemia (APL) undergoing induction therapy with all-trans retinoic acid (ATRA) or arsenic trioxide (ATO). It affected about 20–25% of all patients and so far there are no definitive diagnos...
Autores principales: | Rego, E.M., De Santis, G.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219650/ https://www.ncbi.nlm.nih.gov/pubmed/22110898 http://dx.doi.org/10.4084/MJHID.2011.048 |
Ejemplares similares
-
Epidemiology and Treatment of Acute Promyelocytic Leukemia in Latin America
por: Rego, E.M., et al.
Publicado: (2011) -
Pathogenesis and Treatment of Thrombohemorrhagic Diathesis in Acute Promyelocytic Leukemia
por: Falanga, Anna, et al.
Publicado: (2011) -
Molecular Pathogenesis of Secondary Acute Promyelocytic Leukemia
por: Joannides, M., et al.
Publicado: (2011) -
Differentiation syndrome in patients with acute promyelocytic leukemia
por: Elamin, Nusiba H., et al.
Publicado: (2023) -
Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia
por: Bassi, Sarah Cristina, et al.
Publicado: (2012)